As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...
Don’t miss these highly anticipated fiction and non-fiction releases this spring, which include titles from Chimamanda Ngozi ...
Nila offers guests a rare taste of Indian coastal cuisine, bringing unique flavours and dining experiences to ThailandBANGKOK, THAILAND - Media OutReach Newswire - 21 March 2025 - ONYX Hospitality ...
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...
Two exceptional faculty members have been named Distinguished University Professors in recognition of their outstanding scholarship, teaching, and service.
Open-source AI agent startup Onyx, which queries company documents and tools, raised a $10 million seed round led by Khosla ...
Also, a C.J. Box novel, a magical sword, Alexander Vindman, the Trump campaign and more: the New York Times list for the week ...
The excitement around reasoning models like OpenAI’s o1 and DeepSeek’s R1 got me thinking: How much are businesses actually using them?The answer might be: not as much as you’d think.When I ask ...
Onyx is Backed by Khosla Ventures and First Round Capital, with Participation from Y Combinator and Prominent Investors Onyx ...
China, a Big Tech book about threats, a study of the American right: the New York Times adults’ bestseller list for the week ended Feb. 22.
15d
Screen Rant on MSNThis Onyx Storm Theory Makes Me Feel Better About The Book's Devastating Shadow Wielder RevealOne Onyx Storm theory regarding the book's agonizing shadow wielder reveal makes me feel far more hopeful about Xaden's future in the series.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results